Displaying results 1 - 10 / 70
results / page
What information about granted funding does the service contain?
Granted funding
Funder
Recipient
Starting year
Canine Cognitive Dysfunction; neurodegeneration and pathological mechanisms.Orion Research Foundation srLinda Sofia Rasmus2025Uusia hoitoja lihavuuteen ja tyypin 2 diabetekseen rasvakudoksen mitokondrioiden aineenvaihduntaa aktivoimallaThe Diabetes Research FoundationSini Heinonen2025Novel therapy strategies for prevention and treatment of Hypertrophic CardiomyopathyResearch Council of FinlandItä-Suomen yliopisto2025DynamiSC: Molecular basis of mitochondrial supercomplex function and dysfunctionJane and Aatos Erkko FoundationVivek Sharma2024Investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver diseaseEuropean UnionUniversity of Turku2024Contribution of mitochondrial dysfunction to the diverse phenotypes of Parkinson's disease Mitokondrioiden toimintahäiriöt Parkinsonin taudin moninaisten ilmiasujen taustallaSakari Alhopuro FoundationLaura Kytövuori2024Translating inflammation-induced NF-κB signaling to gene expression in the intestineSvenska kulturfondenVeera Luukkonen2024Novel nanosized GDNF mimetics for the treatment of Parkinson’s disease: focus onto non-dopaminergic featuresEuropean UnionUniversity of Helsinki2024Cell size as driver of stem cell aging and cancerEuropean UnionUniversity of Helsinki2024Seeking improved diagnostics, new therapeutic approaches, and mechanistic understanding of frontotemporal dementiaResearch Council of FinlandPohjois-Savon hyvinvointialue2024
Canine Cognitive Dysfunction; neurodegeneration and pathological mechanisms.
2025
Uusia hoitoja lihavuuteen ja tyypin 2 diabetekseen rasvakudoksen mitokondrioiden aineenvaihduntaa aktivoimalla
2025
Novel therapy strategies for prevention and treatment of Hypertrophic Cardiomyopathy
2025
DynamiSC: Molecular basis of mitochondrial supercomplex function and dysfunction
2024
Investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease
2024
Contribution of mitochondrial dysfunction to the diverse phenotypes of Parkinson's disease Mitokondrioiden toimintahäiriöt Parkinsonin taudin moninaisten ilmiasujen taustalla
2024
Translating inflammation-induced NF-κB signaling to gene expression in the intestine
2024
Novel nanosized GDNF mimetics for the treatment of Parkinson’s disease: focus onto non-dopaminergic features
2024
Cell size as driver of stem cell aging and cancer
2024
Seeking improved diagnostics, new therapeutic approaches, and mechanistic understanding of frontotemporal dementia
2024